2000
DOI: 10.1046/j.1423-0410.2000.7910034.x
|View full text |Cite
|
Sign up to set email alerts
|

Improved Sensitivity in the Measurement of Residual Leukocytes in Platelet Products Using an Automated Leukocyte Counter

Abstract: The instrument provides a new method of enumerating residual leukocytes in platelet products with better sensitivity and easier procedure compared to the Nageotte method and will be useful for quality assurance purposes at blood centers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2002
2002
2005
2005

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…The increasing use of leucocyte‐reduced platelet concentrates (PCs) has raised the need for a simple, stable and accurate routine method for counting low numbers of leucocytes and different methods have been suggested [1–6]. To determine a low number of residual leucocytes with a high precision, it is advantageous to use a reference population with a known number of particles, which allows the determination of leucocyte concentration.…”
Section: Introductionmentioning
confidence: 99%
“…The increasing use of leucocyte‐reduced platelet concentrates (PCs) has raised the need for a simple, stable and accurate routine method for counting low numbers of leucocytes and different methods have been suggested [1–6]. To determine a low number of residual leucocytes with a high precision, it is advantageous to use a reference population with a known number of particles, which allows the determination of leucocyte concentration.…”
Section: Introductionmentioning
confidence: 99%
“…It is generally accepted that hemacytometer WBC counts are variable, and this technology may not be adequate with the degree of WBC reduction obtained using new technologies 18 . Statistical QC monitoring of WBC‐reduced blood components would also benefit from technologies that enumerate residual WBCs that are more sensitive and more reproducible than that of the Nageotte chamber 19 . Alternative measures of platelet quality that may correlate better with in vivo platelet viability could be incorporated into the process model 20 .…”
Section: Discussionmentioning
confidence: 99%